Welcome to Memorial Sloan Kettering Cancer Center’s radiation oncology residency program. With 24 residents and 57 faculty members at our Manhattan campus, we are one of the largest radiation oncology training programs in the country. Our residents come from diverse educational and personal backgrounds, bringing their unique strengths to our residency.
Throughout their four years of training, our residents work one-on-one with leaders in clinical radiation oncology, medical physics, translational research, and basic science. Residents become highly trained in modern radiotherapy techniques, including proton therapy, radiosurgery, image-guided radiotherapy, brachytherapy, and procedures such as intraoperative radiation therapy, total body irradiation, and total skin electron beam therapy.
As part of training in a comprehensive cancer center, residents also routinely learn from experts in surgical oncology, medical oncology, and translational medicine. A dedicated year of protected research time provides residents an opportunity to participate in scholarly clinical and/or laboratory research.
Our graduates leave this program well prepared to become leaders in radiation oncology.
Our Mission
We train future leaders in radiation oncology by providing a collaborative, multidisciplinary clinical and academic experience at one of the world’s premier cancer centers.
We seek to equip our graduates with the skills needed to diagnose and treat both common and rare oncological conditions; to become innovators in clinical, translational, and laboratory-based research; and to provide superior care to future patients.
Program Director’s Message
Lior Braunstein, MD, Assistant Attending
Program Director of MSKCC Radiation Oncology Residency Program
Welcome to the Memorial Sloan Kettering Cancer Center (MSKCC) Radiation Oncology Program, a comprehensive training program at a pioneering institution in cancer care and research. From its 19th-century roots, MSKCC was driven by visionary physicians and scientists, today combining Memorial Hospital with the Sloan Kettering Institute to form a world-class cancer research and treatment facility. Our expansive campus features a main hospital and several outpatient towers, including the cutting-edge Koch Center, ensuring top-tier care across various departments.
MSKCC stands at the forefront of oncological education, offering an exceptional radiation oncology training program deeply integrated with innovative clinical and laboratory research. Our trainees benefit from robust laboratories and core facilities, in addition to collaborations with neighboring elite institutions such as Cornell University and Rockefeller University, enhancing the educational experience with rich multidisciplinary research opportunities. With approximately 350 residents and fellows at MSK, our training environment rivals that of major academic centers, yet focuses exclusively on cancer patients. Our trainees also have ample opportunity to engage in groundbreaking clinical research that sits at the cutting edge of medical science, contributing significantly to MSK’s role as a major hub for clinical trials in New York City and beyond.
Our commitment to our patients extends beyond Manhattan, with clinics throughout New York and New Jersey to serve local communities, reflecting our mission to alleviate the global burden of cancer. MSKCC has been instrumental in the development of modern radiation treatments, from the early use of X-rays in cancer therapy to pioneering high-dose, precision radiation treatments like IMRT and VMAT. The recent addition of a state-of-the-art Proton Center in Manhattan represents our dedication to providing the most advanced care. Aspiring residents can expect a comprehensive training experience that promises not just to educate but to inspire leaders in the field of oncology, empowered by our history of innovation and a supportive, dynamic academic community.